First, the analysis of genetic double-knockout mice for JNK2ΔHepa and NEMOΔHepa (NEMO/JNK2ΔHepa) concurred with our previous findings that Jnk2 knockout in NEMOΔHepa mice showed an improved outcome in HCC development13. The gene discussed is MAPK9; the disease is hepatocellular carcinoma.